Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) EPS (Weighted Average and Diluted): 2012-2024

Historic EPS (Weighted Average and Diluted) for Mimedx Group (MDXG) over the last 13 years, with Dec 2024 value amounting to $0.28.

  • Mimedx Group's EPS (Weighted Average and Diluted) rose 120.00% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.27, marking a year-over-year decrease of 52.63%. This contributed to the annual value of $0.28 for FY2024, which is 34.88% down from last year.
  • Latest data reveals that Mimedx Group reported EPS (Weighted Average and Diluted) of $0.28 as of FY2024, which was down 34.88% from $0.43 recorded in FY2023.
  • In the past 5 years, Mimedx Group's EPS (Weighted Average and Diluted) registered a high of $0.43 during FY2023, and its lowest value of -$0.77 during FY2020.
  • Over the past 3 years, Mimedx Group's median EPS (Weighted Average and Diluted) value was $0.28 (recorded in 2024), while the average stood at $0.13.
  • In the last 5 years, Mimedx Group's EPS (Weighted Average and Diluted) slumped by 220.83% in 2020 and then soared by 230.30% in 2023.
  • Over the past 5 years, Mimedx Group's EPS (Weighted Average and Diluted) (Yearly) stood at -$0.77 in 2020, then soared by 77.92% to -$0.17 in 2021, then tumbled by 94.12% to -$0.33 in 2022, then spiked by 230.30% to $0.43 in 2023, then slumped by 34.88% to $0.28 in 2024.